Literature DB >> 11306244

The mechanism of angiotensin II-induced extracellular signal-regulated kinase-1/2 activation is independent of angiotensin AT(1A) receptor internalisation.

N A Turner1, S G Ball, A J Balmforth.   

Abstract

The aim of this study was to determine whether internalisation of the angiotensin II (Ang II) AT(1A) receptor (AT(1A)R) was a prerequisite for Ang II-induced activation of the extracellular signal-regulated kinases, ERK-1/2. The human embryonic kidney (HEK293) cell line stably transfected with either the wild-type rat AT(1A)R or an internalisation-deficient C-terminal truncated mutant of the AT(1A)R (AT(1A)T318R) was used as a model for these studies. Inhibition of AT(1A)R internalisation by treatment with an inhibitor of clathrin-mediated endocytosis, Concanavalin A (Con A), did not inhibit Ang II-induced ERK-1/2 activation. Furthermore, cells transfected with the internalisation-deficient AT(1A)T318R mutant readily activated ERK-1/2 in response to Ang II. Ang II activated ERK-1/2 via two distinct signalling pathways in HEK-AT(1A)R cells. Approximately half of Ang II-induced ERK-1/2 activation was protein kinase C (PKC)-dependent, and the remainder was calcium- and c-Src-dependent and involved transactivation of the epidermal growth factor receptor (EGFR). In summary, Ang II-induced activation of ERK-1/2 occurs via two distinct pathways in HEK293 cells, neither of which requires AT(1A)R internalisation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306244     DOI: 10.1016/s0898-6568(01)00135-8

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  13 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

2.  5-hydroxytryptamine 4 receptor activation of the extracellular signal-regulated kinase pathway depends on Src activation but not on G protein or beta-arrestin signaling.

Authors:  Gaël Barthet; Bérénice Framery; Florence Gaven; Lucie Pellissier; Eric Reiter; Sylvie Claeysen; Joël Bockaert; Aline Dumuis
Journal:  Mol Biol Cell       Date:  2007-03-21       Impact factor: 4.138

3.  Tenascin C upregulates interleukin-6 expression in human cardiac myofibroblasts via toll-like receptor 4.

Authors:  Azhar Maqbool; Emma J Spary; Iain W Manfield; Michaela Ruhmann; Lorena Zuliani-Alvarez; Filomena O Gamboa-Esteves; Karen E Porter; Mark J Drinkhill; Kim S Midwood; Neil A Turner
Journal:  World J Cardiol       Date:  2016-05-26

4.  Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein.

Authors:  R S Mughal; J L Scragg; P Lister; P Warburton; K Riches; D J O'Regan; S G Ball; N A Turner; K E Porter
Journal:  Diabetologia       Date:  2010-05-12       Impact factor: 10.122

5.  Role of (pro)renin receptor in Ang II-mediated EGF receptor transactivation.

Authors:  Yuki Shibayama; Hirofumi Hitomi; Daisuke Nakano; Hiroyuki Kobori; Hirohito Mori; Kazushi Deguchi; Tsutomu Masaki; Atsuhiro Ichihara; Akira Nishiyama
Journal:  Front Biosci (Elite Ed)       Date:  2013-01-01

6.  Modulatory effect of interleukin-1α on expression of structural matrix proteins, MMPs and TIMPs in human cardiac myofibroblasts: role of p38 MAP kinase.

Authors:  Neil A Turner; Philip Warburton; David J O'Regan; Stephen G Ball; Karen E Porter
Journal:  Matrix Biol       Date:  2010-07-07       Impact factor: 11.583

7.  Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function.

Authors:  Kirsten Riches; Aliah R Alshanwani; Philip Warburton; David J O'Regan; Stephen G Ball; Ian C Wood; Neil A Turner; Karen E Porter
Journal:  J Mol Cell Cardiol       Date:  2014-06-10       Impact factor: 5.000

8.  p38 MAPK alpha mediates cytokine-induced IL-6 and MMP-3 expression in human cardiac fibroblasts.

Authors:  John K Sinfield; Anupam Das; David J O'Regan; Stephen G Ball; Karen E Porter; Neil A Turner
Journal:  Biochem Biophys Res Commun       Date:  2012-12-01       Impact factor: 3.575

9.  Apolipoprotein(a) acts as a chemorepellent to human vascular smooth muscle cells via integrin αVβ3 and RhoA/ROCK-mediated mechanisms.

Authors:  Kirsten Riches; Larissa Franklin; Azhar Maqbool; Michelle Peckham; Matthew Adams; Jacquelyn Bond; Philip Warburton; Nicole T Feric; Marlys L Koschinsky; David J O'Regan; Stephen G Ball; Neil A Turner; Karen E Porter
Journal:  Int J Biochem Cell Biol       Date:  2013-05-31       Impact factor: 5.085

10.  Aberrant phenotype in human endothelial cells of diabetic origin: implications for saphenous vein graft failure?

Authors:  Anna C Roberts; Jai Gohil; Laura Hudson; Kyle Connolly; Philip Warburton; Rakesh Suman; Peter O'Toole; David J O'Regan; Neil A Turner; Kirsten Riches; Karen E Porter
Journal:  J Diabetes Res       Date:  2015-04-08       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.